Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Genetic Care
50%
Ovarian Cancer
50%
Combination Therapy
50%
BRCA Wild-type
50%
Variant Detection
50%
Copy number Variation
50%
Medical Professionals
50%
Japan
50%
Homologous Recombination Deficiency
50%
Gene Alteration
50%
PARP Inhibitors (PARPi)
50%
Hereditary Cancer
50%
Retinitis pigmentosa
50%
Next-generation Sequencing
50%
Pathogen Carrier
25%
Regional Disparities
20%
Multiplex Ligation-dependent Probe Amplification
15%
Multiple Genes
13%
Cancer Genetics
10%
Online Care
10%
Client Acceptance
10%
Internet Security
10%
Genetic nurse
10%
Promising Solution
10%
Client Needs
10%
Counseling Session
10%
Professional Perspectives
10%
Need Perception
10%
Online Communication
10%
Online Methods
10%
Potential Needs
10%
Environmental Security
10%
High Anxiety
10%
Accessible System
10%
Digital Divide
10%
Causative Genes
10%
Specialty Care
10%
In Cancer
10%
Old Age
10%
Genetic Counselors
10%
Genetic Counseling
10%
Internet Use
10%
Total Content
10%
Family Members
10%
Genomic Medicine
10%
Potential Barrier
10%
Questionnaire Survey
10%
Disparities in Access
10%
Patient Engagement
10%
Healthcare Providers
10%
Medicine and Dentistry
Ovarian Cancer
100%
PARP Inhibitor
66%
Germ Cell
58%
BRCA1
58%
Pedigree
50%
Liquid Biopsy
50%
Homologous Recombination
50%
Combination Therapy
50%
Familial Pancreatic Cancer
50%
Gene Mutation
50%
Pancreas Cancer
50%
Family History
25%
Genetic Analysis
25%
Genetic Screening
16%
Cancer Susceptibility
16%
Cancer Prevention
16%
Personalized Medicine
16%
Cell-Free DNA
16%
Case Presentation
12%
Immune Checkpoint Inhibitor
8%
Recombination Repair
8%
Angiogenesis Inhibitor
8%
Biochemistry, Genetics and Molecular Biology
Germline
66%
Germ Cell
66%
RAD51
50%
Copy-Number Variation
50%
Paralogy
50%
Retinitis pigmentosa
50%
PALB2
50%
Next Generation Sequencing
40%
Genetics
21%
BRCA1
16%
Multiplex Ligation-Dependent Probe Amplification
15%
Transcription
8%
